Literature DB >> 27168835

Memory-enhancing effect of aspirin is mediated through opioid system modulation in an AlCl3-induced neurotoxicity mouse model.

Saima Rizwan1, Ayesha Idrees1, Muhammad Ashraf2, Touqeer Ahmed1.   

Abstract

Neurodegenerative disorders such as Alzheimers disease (AD) are multifaceted and there are currently a limited number of therapeutic strategies available to treat them. Aspirin is known to act on multiple therapeutic targets and is a successful anti-inflammatory agent in various tissues. The present study aimed to ascertain the performance of aspirin when employed as a therapeutic agent to treat neurodegeneration on novel targets, including opioid system genes, in an AlCl3-induced neurotoxicity mouse model. The effects of two doses of aspirin (5 and 20 mg/kg aspirin for 12 days) were investigated in an AlCl3-induced neurotoxicity mouse model (150 mg/kg AlCl3 for 12 days). Neurological improvements were assessed through different behavioral tests and the effects of aspirin on opioid system gene expression levels were assessed by reverse transcription-polymerase chain reaction. Both doses resulted in improvements in cognitive behavior. A 5 mg/kg dose of aspirin was revealed to be effective for spatial memory improvement (7.14±0.84 sec), whilst a 20 mg/kg dose was superior for improving extinction learning (7.63±4.04%). Aspirin (5 mg/kg) also significantly improved contextual memory (48.05±10.6%) when compared with the AlCl3-treated group (1.49±0.62%; P<0.001). Aspirin was also observed to significantly decrease δ-opioid receptor expression in the cortex (1.09±0.08 and 1.27±0.08, respectively) at both doses (5 and 20 mg/kg) when compared with the AlCl3-treated group (3.69±1.43; P<0.05). Furthermore, aspirin at 5 mg/kg significantly reduced expression of prodynorphin in the cortex (0.57±0.20) when compared with the AlCl3-treated group (1.95±0.84; P<0.05). Notably, the effect of aspirin was significant in the cortex but not in the hippocampus. In summary, aspirin was effective in ameliorating the AD-like symptoms via the modulation of opioid systems. However, additional studies are required to determine the long term effects of aspirin on such conditions.

Entities:  

Keywords:  amygdala; fear memory; hippocampus; social preference; δ opioid receptors; κ opioid receptors

Year:  2016        PMID: 27168835      PMCID: PMC4840773          DOI: 10.3892/etm.2016.3147

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  58 in total

1.  In vitro fibrillogenesis of the amyloid beta 1-42 peptide: cholesterol potentiation and aspirin inhibition.

Authors:  J R Harris
Journal:  Micron       Date:  2002       Impact factor: 2.251

Review 2.  The molecular basis of opioid receptor function.

Authors:  W F Simonds
Journal:  Endocr Rev       Date:  1988-05       Impact factor: 19.871

3.  Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence.

Authors:  B Platt; G Fiddler; G Riedel; Z Henderson
Journal:  Brain Res Bull       Date:  2001-05-15       Impact factor: 4.077

4.  Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation.

Authors:  Takashi Saito; Nobuhisa Iwata; Satoshi Tsubuki; Yoshie Takaki; Jiro Takano; Shu-Ming Huang; Takahiro Suemoto; Makoto Higuchi; Takaomi C Saido
Journal:  Nat Med       Date:  2005-03-20       Impact factor: 53.440

5.  A comparative study of curcuminoids to measure their effect on inflammatory and apoptotic gene expression in an Aβ plus ibotenic acid-infused rat model of Alzheimer's disease.

Authors:  Touqeer Ahmed; Anwarul-Hassan Gilani
Journal:  Brain Res       Date:  2011-05-18       Impact factor: 3.252

Review 6.  Opiate receptors and opioid peptides.

Authors:  S H Snyder; S R Childers
Journal:  Annu Rev Neurosci       Date:  1979       Impact factor: 12.449

7.  Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.

Authors:  Mie Hirohata; Kenjiro Ono; Hironobu Naiki; Masahito Yamada
Journal:  Neuropharmacology       Date:  2005-08-25       Impact factor: 5.250

8.  Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death.

Authors:  M B Suárez-Fernández; A B Soldado; A Sanz-Medel; J A Vega; A Novelli; M T Fernández-Sánchez
Journal:  Brain Res       Date:  1999-07-24       Impact factor: 3.252

9.  Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer's disease.

Authors:  T Ahmed; S A Enam; A H Gilani
Journal:  Neuroscience       Date:  2010-06-09       Impact factor: 3.590

Review 10.  Modulation of opioid receptor function by protein-protein interactions.

Authors:  Konstantinos Alfaras-Melainis; Ivone Gomes; Raphael Rozenfeld; Venetia Zachariou; Lakshmi Devi
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  5 in total

Review 1.  PPARα Between Aspirin and Plaque Clearance.

Authors:  Sujyoti Chandra; Avik Roy; Dhruv R Patel; Kalipada Pahan
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 2.  Neurotrophic fragments as therapeutic alternatives to ameliorate brain aging.

Authors:  Itzel Ortiz Flores; Samuel Treviño; Alfonso Díaz
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

3.  Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARα.

Authors:  Sujyoti Chandra; Malabendu Jana; Kalipada Pahan
Journal:  J Neurosci       Date:  2018-07-02       Impact factor: 6.167

4.  Effects of Acute and Chronic Exposure to a Mixed Field of Neutrons and Photons and Single or Fractionated Simulated Galactic Cosmic Ray Exposure on Behavioral and Cognitive Performance in Mice.

Authors:  Sarah Holden; Ruby Perez; Reed Hall; Christina M Fallgren; Brian Ponnaiya; Guy Garty; David J Brenner; Michael M Weil; Jacob Raber
Journal:  Radiat Res       Date:  2021-07-01       Impact factor: 3.372

5.  Molecular mechanism of acetylsalicylic acid in improving learning and memory impairment in APP/PS1 transgenic mice by inhibiting the abnormal cell cycle re-entry of neurons.

Authors:  Pei-Pei Guan; Wei-Yan Ding; Pu Wang
Journal:  Front Mol Neurosci       Date:  2022-10-03       Impact factor: 6.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.